WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Black Box Warning
ConditionName:
See full prescribing information for complete Boxed Warning.
ConditionName:
Content
Overview
Chlorphenamine is an anti- allergic agent that is FDA approved for the treatment of allergic rhinitis, common cold. There is a Black Box Warning for this drug as shown here. Common adverse reactions include {{{adverseReactions}}}.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Allergic rhinitis
Dosing Information
The dosage of chlorpheniramine depends on the product. Use the following guidelines: 4-hour allergy tablet - 1 tablet (4 mg) every 4 to 6 hours up to a maximum of 6 tablets in 24 hours; 8-hour allergy tablet - 1 tablet (8 mg) every 8 to 12 hours up to 3 tablets in 24 hours; 12-hour tablet - 1 tablet (12 mg) every 12 hours up to 2 tablets in 24 hours.
For the prevention of allergic rhinitis symptoms, administer chlorpheniramine 4 mg (syrup or plain, uncoated tablet) and increase 3 times daily every 3 days as tolerated until reaching 8 mg 3 times daily. Start before the allergy season (for ragweed - August 1st) and continue until inhalant allergen is gone (first frost in ragweed areas). Most patients develop tolerance to the sedative effect if dose is started low and increased in small increments (only when previous lower dose is tolerated).
Common cold
Dosing Information
For cough, 2 teaspoonfuls of Codeprex(TM) (10 mL; equivalent to codeine 40 mg and chlorpheniramine maleate 8 mg) ORALLY every 12 hours; maximum dose 4 teaspoonfuls in 24 hours.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
Condition1
Developed by:
Class of Recommendation:
Strength of Evidence:
Dosing Information
Dosage
Condition2
There is limited information regarding Off-Label Guideline-Supported Use of Chlorphenamine in adult patients.
Non–Guideline-Supported Use
Condition1
Dosing Information
Dosage
Condition2
There is limited information regarding Off-Label Non–Guideline-Supported Use of Chlorphenamine in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Allergic rhinitis
Dosing Information
Dosage
Common cold
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
Condition1
Developed by:
Class of Recommendation:
Strength of Evidence:
Dosing Information
Dosage
Condition2
There is limited information regarding Off-Label Guideline-Supported Use of Chlorphenamine in pediatric patients.
Non–Guideline-Supported Use
Condition1
Dosing Information
Dosage
Condition2
There is limited information regarding Off-Label Non–Guideline-Supported Use of Chlorphenamine in pediatric patients.
Contraindications
Condition1
Warnings
ConditionName:
See full prescribing information for complete Boxed Warning.
ConditionName:
Content
Description
Precautions
Description
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Chlorphenamine in the drug label.
Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Chlorphenamine in the drug label.